Adaptive Biotechnologies Corp (ADPT) Insider Ownership

Historic Insider Ownership Trends

As of April 17, 2026, the three largest insider holders of ADPT are Chad M Robins (Ceo And Chairman, 2.18Mn shares), Harlan S Robins (Chief Scientific Officer, 1.52Mn shares), Harlan S Robins (Chief Scientific Officer, 1.52Mn shares).

Top Direct Holders

Insider ownership data is derived from the last 60 months of Form 4 SEC filings.
Holder Position Shares (Direct) Shares (Indirect) Report Date
Chad M Robins Ceo And Chairman 2,180,518 0 08 Apr, 2026
Harlan S Robins Chief Scientific Officer 1,522,058 0 13 Mar, 2026
Harlan S Robins Chief Scientific Officer 1,522,058 0 13 Mar, 2026
Harlan S Robins Chief Scientific Officer 1,512,058 0 10 Apr, 2026
Harlan S Robins Chief Scientific Officer 1,512,058 0 10 Apr, 2026
Tycho Peterson Chief Financial Officer 531,553 0 06 Mar, 2024
Tycho Peterson Chief Financial Officer 531,553 0 06 Mar, 2024
Tycho Peterson Chief Financial Officer 531,553 0 06 Mar, 2024
Tycho Peterson Chief Financial Officer 531,553 0 06 Mar, 2024
Julie Rubinstein President And Coo 447,202 0 02 Apr, 2026
Julie Rubinstein President And Coo 434,188 0 08 Apr, 2026
Julie Rubinstein President And Coo 434,188 0 08 Apr, 2026
Susan Bobulsky Chief Commercial Officer, Mrd 427,775 0 13 Mar, 2026
Susan Bobulsky Chief Commercial Officer, Mrd 427,775 0 13 Mar, 2026
Susan Bobulsky Chief Commercial Officer, Mrd 427,775 0 13 Mar, 2026
Susan Bobulsky Chief Commercial Officer, Mrd 427,775 0 13 Mar, 2026
Julie Rubinstein President And Coo 421,174 0 13 Apr, 2026
Francis Lo Chief People Officer 291,374 0 13 Mar, 2026
Francis Lo Chief People Officer 291,374 0 13 Mar, 2026
Sharon Benzeno Chief Commercial Ofc Imm Med 272,751 0 13 Mar, 2026
Sharon Benzeno Chief Commercial Ofc Imm Med 272,751 0 13 Mar, 2026
Sharon Benzeno Chief Commercial Ofc Imm Med 272,751 0 13 Mar, 2026
Sharon Benzeno Chief Commercial Ofc Imm Med 272,751 0 13 Mar, 2026
Francis Lo Chief People Officer 271,154 0 10 Apr, 2026
Francis Lo Chief People Officer 271,154 0 10 Apr, 2026
Kyle Piskel Chief Financial Officer 259,840 0 13 Mar, 2026
Kyle Piskel Chief Financial Officer 259,840 0 13 Mar, 2026
Kyle Piskel Chief Financial Officer 259,840 0 13 Mar, 2026
Kyle Piskel Chief Financial Officer 259,840 0 13 Mar, 2026
Peter M Neupert - 240,315 0 06 Mar, 2026
Peter M Neupert - 240,315 0 06 Mar, 2026
Peter M Neupert - 240,315 0 06 Mar, 2026
Nitin Sood Chief Commercial Officer, Mrd 214,808 0 08 Aug, 2023
Nitin Sood Chief Commercial Officer, Mrd 214,808 0 08 Aug, 2023
Nitin Sood Chief Commercial Officer, Mrd 214,808 0 08 Aug, 2023
Nitin Sood Chief Commercial Officer, Mrd 214,808 0 08 Aug, 2023
R Mark Adams Chief Operating Officer 175,361 0 12 Apr, 2023
Stacy L Taylor Svp And General Counsel 139,365 0 23 Aug, 2024
Stacy L Taylor Svp And General Counsel 139,365 0 23 Aug, 2024
Stacy L Taylor Svp And General Counsel 139,365 0 23 Aug, 2024
Stacy L Taylor Svp And General Counsel 139,365 0 23 Aug, 2024
Katey Einterz Owen - 88,254 0 06 Mar, 2026
Katey Einterz Owen - 88,254 0 06 Mar, 2026
Katey Einterz Owen - 88,254 0 06 Mar, 2026
Katey Einterz Owen - 88,254 0 06 Mar, 2026
Michael J Pellini - 69,690 0 06 Mar, 2025
Michael J Pellini - 69,690 0 06 Mar, 2025
Michael J Pellini - 69,690 0 06 Mar, 2025
Michael J Pellini - 69,690 0 06 Mar, 2025
Robert Hershberg - 62,347 0 06 Mar, 2026
Robert Hershberg - 62,347 0 06 Mar, 2026
Robert Hershberg - 62,347 0 06 Mar, 2026
Leslie Trigg - 25,907 0 08 Mar, 2023
Leslie Trigg - 25,907 0 08 Mar, 2023
Leslie Trigg - 25,907 0 08 Mar, 2023
Leslie Trigg - 25,907 0 08 Mar, 2023
Kevin T Conroy - 22,968 0 08 Mar, 2023
Kevin T Conroy - 22,968 0 08 Mar, 2023
Kevin T Conroy - 22,968 0 08 Mar, 2023
Chad M Cohen Chief Financial Officer 21,604 0 23 Dec, 2021
Chad M Cohen Chief Financial Officer 21,604 0 23 Dec, 2021
Chad M Cohen Chief Financial Officer 21,604 0 23 Dec, 2021
Lance Baldo Chief Medical Officer 17,171 0 10 Mar, 2022
Lance Baldo Chief Medical Officer 17,171 0 10 Mar, 2022
Lance Baldo Chief Medical Officer 17,171 0 10 Mar, 2022
Lance Baldo Chief Medical Officer 17,171 0 10 Mar, 2022
Michelle Renee Griffin - 15,625 0 13 Mar, 2026
Michelle Renee Griffin - 15,625 0 13 Mar, 2026
Michelle Renee Griffin - 15,625 0 13 Mar, 2026
Michelle Renee Griffin - 15,625 0 13 Mar, 2026
Jyoti Palaniappan Svp, Diagnostics, T Detect 9,158 0 19 Jul, 2021
Jyoti Palaniappan Svp, Diagnostics, T Detect 9,158 0 19 Jul, 2021
Jyoti Palaniappan Svp, Diagnostics, T Detect 9,158 0 19 Jul, 2021
Jyoti Palaniappan Svp, Diagnostics, T Detect 9,158 0 19 Jul, 2021

* Please note that the shares above only reflect shares from the fund portfolio and the institutional portfolio. Shares from the personal portfolio are excluded from this Institutional Ownership Page. See these insiders' latest transactions here on Insider Page.

Recent Insider Transactions

Detailed insider trading activity based on Form 4 SEC filings.
Download Data
Transaction Date Insider Name Security Class Transaction Type Shares Traded Price Shares Remaining Ownership Code
09 Apr, 2026 Julie Rubinstein Common Stock A 14,722 $7.27 448,910 D M
09 Apr, 2026 Julie Rubinstein Common Stock D 16,960 $13.79 431,950 D S
09 Apr, 2026 Julie Rubinstein Common Stock D 2,100 $14.44 429,850 D S
10 Apr, 2026 Julie Rubinstein Common Stock A 14,722 $7.27 444,572 D M
10 Apr, 2026 Julie Rubinstein Common Stock D 18,660 $12.75 425,912 D S
10 Apr, 2026 Julie Rubinstein Common Stock D 400 $13.48 425,512 D S
13 Apr, 2026 Julie Rubinstein Common Stock A 8,109 $7.27 433,621 D M
13 Apr, 2026 Julie Rubinstein Common Stock A 6,613 $8.46 440,234 D M
13 Apr, 2026 Julie Rubinstein Common Stock D 15,722 $12.95 424,512 D S
13 Apr, 2026 Julie Rubinstein Common Stock D 3,338 $14.08 421,174 D S
09 Apr, 2026 Julie Rubinstein Stock Option (right to buy) D 14,722 $0.00 22,831 D M
10 Apr, 2026 Julie Rubinstein Stock Option (right to buy) D 14,722 $0.00 8,109 D M
13 Apr, 2026 Julie Rubinstein Stock Option (right to buy) D 8,109 $0.00 0 D M
13 Apr, 2026 Julie Rubinstein Stock Option (right to buy) D 6,613 $0.00 192,936 D M
08 Apr, 2026 Harlan S Robins Common Stock D 10,000 $14.85 1,512,058 D S
08 Apr, 2026 Francis Lo Common Stock A 2,344 $3.99 293,718 D M
08 Apr, 2026 Francis Lo Common Stock D 22,564 $15.07 271,154 D S
08 Apr, 2026 Francis Lo Stock Option (right to buy) D 2,344 $0.00 88,297 D M
06 Apr, 2026 Chad M Robins Common Stock D 83,332 $14.41 2,217,781 D S
06 Apr, 2026 Julie Rubinstein Common Stock A 14,722 $7.27 461,924 D M